Dosimetric comparison of intensity-modulated, conformal, and four-field pelvic radiotherapy boost plans for gynecologic cancer: a retrospective planning study

被引:44
作者
Chan, Philip [1 ,3 ,4 ]
Yeo, Inhwan [2 ,3 ]
Perkins, Gregory [2 ]
Fyles, Anthony [1 ,3 ,4 ]
Milosevic, Michael [1 ,3 ,4 ]
机构
[1] Princess Margaret Hosp, Dept Radiat Oncol, Univ Hlth Network, Toronto, ON M4X 1K9, Canada
[2] Princess Margaret Hosp, Dept Radiat Phys, Univ Hlth Network, Toronto, ON, Canada
[3] Univ Toronto, Dept Radiat Oncol, Toronto, ON, Canada
[4] Univ Toronto, Inst Med Sci, Toronto, ON M5S 1A1, Canada
关键词
Planning Target Volume; Rectal Volume; Planning Target Volume Coverage; Brachytherapy Boost; Serous Uterine Carcinoma;
D O I
10.1186/1748-717X-1-13
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: To evaluate intensity-modulated radiation therapy (IMRT) as an alternative to conformal radiotherapy (CRT) or 4-field box boost (4FB) in women with gynecologic malignancies who are unsuitable for brachytherapy for technical or medical reasons. Methods: Dosimetric and toxicity information was analyzed for 12 patients with cervical (8), endometrial (2) or vaginal (2) cancer previously treated with external beam pelvic radiotherapy and a CRT boost. Optimized IMRT boost treatment plans were then developed for each of the 12 patients and compared to CRT and 4FB plans. The plans were compared in terms of dose conformality and critical normal tissue avoidance. Results: The median planning target volume (PTV) was 151 cm(3) (range 58-512 cm(3)). The median overlap of the contoured rectum with the PTV was 15 (1-56) %, and 11 (4-35) % for the bladder. Two of the 12 patients, both with large PTVs and large overlap of the contoured rectum and PTV, developed grade 3 rectal bleeding. The dose conformity was significantly improved with IMRT over CRT and 4FB (p <= 0.001 for both). IMRT also yielded an overall improvement in the rectal and bladder dose-volume distributions relative to CRT and 4FB. The volume of rectum that received the highest doses (> 66% of the prescription) was reduced by 22% (p < 0.001) with IMRT relative to 4FB, and the bladder volume was reduced by 19% (p < 0.001). This was at the expense of an increase in the volume of these organs receiving doses in the lowest range (< 33%). Conclusion: These results indicate that IMRT can improve target coverage and reduce dose to critical structures in gynecologic patients receiving an external beam radiotherapy boost. This dosimetric advantage will be integrated with other patient and treatment-specific factors, particularly internal tumor movement during fractionated radiotherapy, in the context of a future image-guided radiation therapy study.
引用
收藏
页数:10
相关论文
共 37 条
[1]   Charged photoparticle production in tissue during radiotherapy [J].
Allen, PD ;
Chaudhri, MA .
MEDICAL PHYSICS, 1997, 24 (06) :837-839
[2]  
BACHTIARY B, 2005, INT J RAD O IN PRESS
[3]   Intrafractional movement of the uterus and cervix in patients with cervix cancer receiving radiotherapy: an MRI-based point-of-interest (POI) analysis [J].
Chan, P ;
Milosevic, M ;
Fyles, A ;
Jaffray, D ;
Dinniwell, R ;
Kirilova, A ;
Lockwood, G ;
Syed, A ;
Manchul, L ;
Levin, W .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2004, 60 (01) :S305-S305
[4]  
Chatani M., 1995, Strahlentherapie und Onkologie, V171, P655
[5]   DOSE TUMOR RESPONSE FOR CARCINOMA OF CERVIX - AN ANALYSIS OF 594 PATIENTS TREATED BY RADIOTHERAPY [J].
CHOY, D ;
WONG, LC ;
SHAM, J ;
NGAN, HYS ;
MA, HK .
GYNECOLOGIC ONCOLOGY, 1993, 49 (03) :311-317
[6]  
COIA L, 1990, CANCER-AM CANCER SOC, V66, P2451, DOI 10.1002/1097-0142(19901215)66:12<2451::AID-CNCR2820661202>3.0.CO
[7]  
2-5
[8]   Intensity-modulated radiotherapy as primary treatment for prostate cancer: Acute toxicity in 114 patients [J].
De Meerleer, G ;
Vakaet, L ;
Meersschout, S ;
Villeirs, G ;
Verbaeys, A ;
Oosterlinck, W ;
De Neve, W .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2004, 60 (03) :777-787
[9]   TIME-COURSE AND INCIDENCE OF LATE COMPLICATIONS IN PATIENTS TREATED WITH RADIATION-THERAPY FOR FIGO STAGE IB CARCINOMA OF THE UTERINE CERVIX [J].
EIFEL, PJ ;
LEVENBACK, C ;
WHARTON, JT ;
OSWALD, MJ .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1995, 32 (05) :1289-1300
[10]   Pelvic irradiation with concurrent chemotherapy versus pelvic and para-aortic irradiation for high-risk cervical cancer: An update of radiation therapy oncology group trial (RTOG) 90-01 [J].
Eifel, PJ ;
Winter, K ;
Morris, M ;
Levenback, C ;
Grigsby, PW ;
Cooper, J ;
Rotman, M ;
Gershenson, D ;
Mutch, DG .
JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (05) :872-880